| Financial Year |
March 31 2023 |
| Monetary Funds |
23,905,057,463.00 |
| Held-for-trading Financial Assets |
-- |
| Notes Receivable |
2,383,802.00 |
| Accounts Receivable |
2,680,167,070.00 |
| Advances to Suppliers |
345,434,941.00 |
| Other Receivables |
117,072,881.00 |
| Amounts Due From Related Companies |
-- |
| Interest Receivable |
-- |
| Dividend Receivable |
-- |
| Inventories |
4,869,637,489.00 |
| Among: Consumptive Biological Assets |
-- |
| Non-Current Assets Maturing Within One Year |
32,328,113.00 |
| Other Current Assets |
349,075,785.00 |
| Total Current Assets |
32,301,157,544.00 |
| Available-for-Sale Financial Asset |
-- |
| Held-to-maturity Investments |
-- |
| Long-Term Account Receivable |
17,671,885.00 |
| Long-term Equity Investment |
64,660,562.00 |
| Investment Properties |
42,899,906.00 |
| Fixed Assetes |
4,431,191,065.00 |
| Under-construction Projects |
1,757,437,642.00 |
| Construction Materials |
-- |
| Disposal of Fixed Assets |
-- |
| Capitalized Biological Assets |
-- |
| Oil and Gas Assets |
-- |
| Intangible Assets |
1,958,855,703.00 |
| R&D expenses |
317,005,153.00 |
| Goodwill |
4,417,372,947.00 |
| Long-Term Deferred and Prepaid Expenses |
78,511,137.00 |
| Deferred Income Tax Assets |
714,009,738.00 |
| Other Non-Current Assets |
2,218,284,604.00 |
| Sub-Total of Non-Current Assets |
16,257,556,963.00 |
| Total Assets |
48,558,714,507.00 |
| Short-Term Loans |
-- |
| Trading Financial liabilities |
-- |
| Notes Payable |
-- |
| Accounts Payable |
2,913,263,344.00 |
| Accounts Received In Advance |
173,802.00 |
| Employee Compensation Payable |
2,324,784,235.00 |
| Taxes Payable |
294,298,372.00 |
| Interest Payable |
-- |
| Dividend Payable |
-- |
| Other payables |
1,569,104,924.00 |
| Due to Related Companies |
-- |
| Non-Current Liabilities Due Within One Year |
98,323,900.00 |
| Other Current Liabilities |
519,566,908.00 |
| Sub-Total of Current Liabilities |
11,612,155,155.00 |
| Long-term Loans |
-- |
| Bonds Payable |
-- |
| Long-Term Accounts Payable |
-- |
| Special Payable |
-- |
| Estimatied Liabilities |
244,863,107.00 |
| Deferred Income Tax Liabilities |
175,810,460.00 |
| Other Non-Current Liabilities |
164,508,214.00 |
| Sub-Total of Non-Current Liabilities |
2,274,567,228.00 |
| Total Liabilities |
13,886,722,383.00 |
| Paid-In Capital(Or Share Stock) |
1,212,441,394.00 |
| Capital Surplus |
7,604,291,301.00 |
| Surplus Reserve |
607,845,633.00 |
| LESS:Treasury Stock |
999,990,786.00 |
| Undistributed Profits |
26,331,828,776.00 |
| Minority Stockholder's Interest |
19,508,770.00 |
| Foreign Currency Capital |
-- |
| Abnormal Management Project Income Adjusted |
-- |
| Total Owners' Equity Attributable to Parent(Stockholder's Interest) |
34,652,483,354.00 |
| Owner's Equity（Stockholder's Equity） |
34,671,992,124.00 |
| Total Liabilities and Owner's Equity（Stockholder's Equity） |
48,558,714,507.00 |
